Oncology & Cancer

New therapy combination prolongs survival in dogs with lymphoma

A new immunotherapy for companion dogs with advanced-stage non-Hodgkin lymphoma (NHL) has been shown to improve survival while maintaining quality of life, according to a study published in the journal Scientific Reports. ...

Oncology & Cancer

Nuclear power plants do not raise risk of leukaemia in children

Young children who live near nuclear power plants do not have a greater risk of developing childhood leukaemia or non-Hodgkin Lymphoma according to research published in the British Journal of Cancer today (Friday).

Oncology & Cancer

Non-Hodgkin lymphoma survival doubles since early 1970s

More than half of patients diagnosed with Non-Hodgkin Lymphoma (NHL) are now surviving the disease thanks to improved diagnosis and treatment, according to a new report1 from Cancer Research UK.

Other

Amgen buys Micromet for anti-leukemia drug

Biotech giant Amgen said Thursday it was buying the German-American cancer research firm Micromet, giving it access to Micromet's promising leukemia therapy.

page 2 from 5